Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes have?
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes has 249 citations in the OpenAlex counts ScholarIQ stores.
When was Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes published?
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes has 2025 year in the ScholarIQ index.
What is the open-access status of Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes?
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes has green oa status in the ScholarIQ index.
What is the DOI of Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes?
The DOI for Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes is on the source record.
What is the PMID of Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes?
The PMID for Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes is on the source record.
What is the OpenAlex record for Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes?
The OpenAlex for Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes is on the source record.